Peptides, Price Hikes & the Pursuit of Happiness

Beware the Wellness Boom: Red Flags, Celebrity Endorsements, and Medical Hype

In this episode of After Hours Clinic, Andrew Lane and Dr. David Janarious examine the rapid growth of wellness-focused telehealth companies and the promises driving the modern health optimization movement. They discuss the rise of online services offering hormones, peptides, supplements, ADHD treatments, and longevity programs, while sharing firsthand experiences evaluating some of the industry's biggest players. The conversation explores how telehealth transformed healthcare after COVID, where convenience can provide real value, and where marketing often outpaces evidence. Andrew and Dr. Dave break down common warning signs consumers should watch for, including proprietary testing, branded supplements, celebrity endorsements, protocol-driven medicine, and limited physician involvement. They also explain what meaningful patient care looks like and why long-term doctor-patient relationships remain essential in an increasingly commercialized healthcare landscape. ______________________________________________________________________ Key Points From This Episode: [00:00:00] Introduction to the wellness telehealth boom. [00:01:15] Growth of online wellness and longevity companies. [00:02:32] How COVID accelerated telehealth adoption. [00:05:17] Consumer frustration with traditional healthcare barriers. [00:07:12] Rise of cash-based telehealth businesses. [00:08:32] Longevity influencers and optimization culture. [00:09:41] Celebrity and podcast influence on healthcare decisions. [00:11:26] COVID-era mistrust and alternative health services. [00:13:55] Patient autonomy versus one-size-fits-all prescribing. [00:14:58] Secret-shopping major telehealth platforms. [00:16:21] Hormone therapy and ADHD service concerns. [00:18:38] Benefits and limitations of compounded GLP-1 services. [00:19:32] The Male Excel testosterone prescribing experience. [00:23:01] Risks of testosterone treatment without monitoring. [00:25:46] Personal experiences with testosterone therapy. [00:27:50] The Done First ADHD prescribing controversy. [00:29:47] The appearance of professionalism in telehealth marketing. [00:30:56] Cerebral and stimulant prescribing concerns. [00:32:15] Introducing key telehealth red flags. [00:33:10] Red Flag #1: Excessive focus on health data. [00:34:48] Why testing should drive meaningful decisions. [00:36:54] Evidence-based testing versus novelty biomarkers. [00:38:24] Red Flag #2: Branded supplements and products. [00:42:25] Red Flag #3: Celebrity endorsements. [00:46:47] Red Flag #4: “Root cause” and functional medicine marketing. [00:49:17] How vulnerable patients can be targeted. [00:52:23] Red Flag #5: Limited physician involvement. [00:53:01] Physician training versus mid-level training. [00:56:47] Volume-driven healthcare and assembly-line medicine. [00:58:25] The value of time and continuity in patient care. [01:00:00] Building trust through long-term relationships. [01:02:31] Taking ownership of patient care coordination. [01:04:08] The importance of a healthcare team leader. [01:06:14] Closing thoughts on telehealth and consumer education. Links: * Better Life: https://www.joinbetterlife.com/ [https://www.joinbetterlife.com/] * Dr. David Janarious on LinkedIn: https://www.linkedin.com/in/david-janarious-8b6073280 [https://www.linkedin.com/in/david-janarious-8b6073280] * Production and editing by The Podcast Consultant: https://thepodcastconsultant.com [https://thepodcastconsultant.com]

HPV Vaccines and Cancer Prevention in Men

In this episode of After Hours Clinic, Andrew Lane and Dr. David Janarious examine new research published in JAMA on the HPV vaccine and its association with reduced cancer risk in males. The discussion breaks down how the human papillomavirus contributes to cervical, head and neck, esophageal, anal, and penile cancers, and why vaccination recommendations expanded from girls to boys over the past two decades. Andrew reviews the strengths and limitations of the large population study, including the reported reduction in HPV-related cancers among vaccinated males. The conversation also addresses vaccine safety data, public distrust of medical institutions, risk versus benefit analysis, and whether HPV vaccination may still offer value later in adulthood. Key Points From This Episode: [00:00:00] Introduction to the After Hours Clinic podcast and episode theme [00:00:54] Introduction to the JAMA article examining HPV vaccines and cancer prevention in males. [00:01:35] Evidence-based perspectives on vaccines and individualized medical decision-making. [00:03:17] Overview of HPV, cervical cancer risk, and the development of the HPV vaccine. [00:05:56] Why HPV vaccination recommendations expanded to boys and men. [00:07:24] HPV-associated cancers beyond cervical cancer, including head and neck cancers. [00:08:27] Breakdown of the study design involving nearly one million young males. [00:09:50] Study findings showing reduced rates of HPV-related cancers in vaccinated males. [00:10:07] Limitations of population-based cohort studies versus randomized controlled trials. [00:12:16] Discussion of vaccine risks, adverse event reporting, and CDC monitoring systems. [00:14:42] How VAERS and other surveillance systems track vaccine safety signals. [00:16:19] Reported side effects associated with the HPV vaccine and their rarity. [00:18:18] Explanation of the nine-valent HPV vaccine and the strains it targets. [00:20:49] The seriousness of HPV-associated head, neck, and esophageal cancers. [00:23:59] How large-scale vaccine databases contribute to long-term public health research. [00:24:37] Interpretation of the study’s cancer reduction statistics and age limitations. [00:26:57] Recommendations for HPV vaccination in children and adolescents. [00:27:19] Public distrust of vaccines and the need for clearer medical communication. [00:29:29] Discussion around HPV vaccination for adults over age 26. [00:31:23] Questions surrounding HPV dormancy, immunity, and long-term cancer risk. [00:34:56] Reduced vaccine effectiveness after prior HPV exposure. [00:37:40] Comparing vaccine interventions with supplements and longevity products. [00:40:03] Why the hosts consider the HPV vaccine a worthwhile intervention for children. [00:41:01] Future plans to examine additional vaccines with strong evidence for benefit. Links: * * Better Life: https://www.joinbetterlife.com/ [https://www.joinbetterlife.com/] * Dr. David Janarious on LinkedIn: https://www.linkedin.com/in/david-janarious-8b6073280 [https://www.linkedin.com/in/david-janarious-8b6073280] * * Production and editing by The Podcast Consultant: https://thepodcastconsultant.com [https://thepodcastconsultant.com]

Rapamycin for Longevity and the Controversy over Pediatric Vaccinations

In this episode of After Hours Clinic, Andrew Lane and Dr. David Janarious examine two controversial and rapidly evolving topics in modern medicine: rapamycin and vaccine skepticism. Dr. Janarious breaks down the science behind rapamycin, a low-cost transplant medication now being studied for its potential role in longevity, muscle preservation, and ovarian aging. They analyze recent clinical trials, discuss the limitations of current data, and explore why the drug continues to generate interest in the biohacking and anti-aging communities. The conversation then shifts to vaccines, informed consent, and the growing tension between physicians and patients. Together, they unpack changing attitudes toward medical authority, individualized care, and the importance of transparent risk-benefit discussions in today’s healthcare landscape.    Key Points From This Episode:  [00:00:00] Introduction to rapamycin and its growing role in longevity discussions.  [00:01:41] How rapamycin works through mTOR inhibition and cellular “housekeeping.”  [00:03:14] Mouse studies showing lifespan extension with rapamycin treatment.  [00:05:47] Why human longevity trials are difficult and researchers focus on aging markers instead.  [00:06:46] Overview of the 12-week rapamycin exercise study in sedentary older adults.  [00:08:15] Discussion of disappointing trial results and limitations of the study design.  [00:10:26] Explanation of epigenetic clocks and biological aging measurements.  [00:12:04] Why current biological age testing may still be premature.  [00:13:27] Safety considerations and adverse events associated with rapamycin use.  [00:14:16] Why the recent rapamycin study does not end interest in the drug’s longevity potential.  [00:16:15] Breakdown of the PEARL trial and changes in lean muscle mass.  [00:17:15] Significant muscle gain findings in women taking higher-dose rapamycin.  [00:19:19] Improvements in arthritis-related pain scores reported in the PEARL trial.  [00:20:36] Connections between rapamycin benefits in female mice and human trial findings.  [00:21:51] The VIBRANT trial and preliminary findings on ovarian aging reduction.  [00:23:47] Ongoing rapamycin studies and thoughts on prescribing it off-label.  [00:24:43] Comparison of rapamycin with other longevity-focused medications like GLP-1s and SGLT2 inhibitors.  [00:26:23] Transition into discussion around vaccine hesitancy and physician burnout.  [00:27:20] Pediatricians expressing frustration over increasing vaccine skepticism among parents.  [00:28:47] Criticism of paternalism within the medical establishment.  [00:30:50] The importance of informed consent and discussing vaccine risks transparently.  [00:32:28] Concerns about dismissing patient questions instead of addressing them directly.  [00:33:22] Debate over pediatric practices dismissing unvaccinated families.  [00:35:12] Discussion about shared medical decision-making and patient autonomy.  [00:36:31] How Better Life’s care philosophy emphasizes collaboration with patients.  [00:37:52] Why many physicians may not fully understand the vaccine data themselves.  [00:39:44] Dr. Janarious shares a personal example of re-evaluating assumptions about alkaline diets.  [00:41:38] Potential positive outcomes from greater public involvement in medical decisions.  [00:42:33] The need for more individualized and prioritized vaccine recommendations.  [00:43:01] Vaccines Dr. Janarious strongly supports, including measles, meningococcal, and HPV vaccines.  [00:47:09] Why modern healthcare conversations require more collaboration and nuance.  [00:49:03] Final thoughts on avoiding conflict and improving doctor-patient communication.      Links:    * Better Life: https://www.joinbetterlife.com/ [https://www.joinbetterlife.com/]     * Dr. David Janarious on LinkedIn: https://www.linkedin.com/in/david-janarious-8b6073280 [https://www.linkedin.com/in/david-janarious-8b6073280]     * Production and editing by The Podcast Consultant: https://thepodcastconsultant.com [https://thepodcastconsultant.com/]

Emergency Room Hell: Why You Should Stay Out of the ER

In this episode of After Hours Clinic, Dr. David Janarious and Andrew Lane break down a troubling trend highlighted in a recent Atlantic article: patients stuck in emergency rooms for days while awaiting proper hospital admission. They examine how financial incentives, staffing shortages, and system strain have reshaped emergency care, often leaving patients with suboptimal treatment at high cost. The discussion blends real patient stories with clinical insight, including cases where avoiding the ER led to better outcomes. They also address overlooked topics like hospice care, end-of-life planning, and how stronger relationships with primary care providers can help patients handle medical decisions more effectively. ______________________________________________________________________ Key Points From This Episode: [00:00:00] Introduction to the After Hours Clinic podcast and episode theme [00:00:20] Andrew introduces the article on ER overcrowding and patient delays [00:05:12] Overview of the article: end-of-life care and prolonged ER stays [00:06:08] Realities of ER boarding and lack of proper inpatient care [00:07:29] Andrew’s personal ER experience with his daughter [00:08:20] Difference between ER care and true hospital admission [00:10:56] Financial incentives driving ER overcrowding and hospital decisions [00:12:58] Elective procedures vs. urgent admissions and system priorities [00:15:27] David’s experience in urgent care managing ER-level cases [00:17:55] Value of avoiding the ER through proactive medical care [00:19:23] Why the ER is often the worst place for non-emergent care [00:21:26] Misuse of ER services due to limited access to primary care [00:22:08] Case study: missed diagnosis of a serious condition in the ER [00:26:13] Story of pediatric care avoiding unnecessary ER visit [00:28:55] Discussion of risk tolerance and outpatient decision-making [00:32:06] Example of avoiding ER admission through informed care [00:34:50] Hospice care success story and its benefits [00:35:48] Missing hospice discussion in the article’s narrative [00:37:19] Reflection on dignity in end-of-life care [00:40:08] Lack of public understanding around death and hospital care [00:41:04] Andrew shares his grandfather’s medical journey [00:43:31] Explanation of palliative care vs. hospice [00:45:45] Discussion on physician-assisted death and comfort measures [00:49:04] Broader implications for health literacy and planning [00:51:18] Final takeaway: avoid the ER when possible and build trusted medical relationships Links: * Better Life: https://www.joinbetterlife.com/ [https://www.joinbetterlife.com/] * Dr. David Janarious on LinkedIn: https://www.linkedin.com/in/david-janarious-8b6073280 [https://www.linkedin.com/in/david-janarious-8b6073280] * Production and editing by The Podcast Consultant: https://thepodcastconsultant.com [https://thepodcastconsultant.com]

Peptides, Price Hikes & the Pursuit of Happiness

In this episode of After Hours Clinic, Dr. David Janarious and Andrew Lane examine the growing tension between medical science and modern wellness trends. They unpack the realities behind rising prescription drug costs and why meaningful reform remains unlikely. The conversation then shifts to peptides, clarifying what they are, where they can be useful, and why much of the hype may be misplaced. They also address the risks of relying on unverified sources, including AI tools and black-market products, when making health decisions. The episode wraps with a discussion on happiness, focusing on practical ways to improve quality of life beyond strict optimization, including hobbies, goal-setting, and social connection.    Key Points From This Episode:  [00:00:00] Lighthearted discussion on indulgences, balance, and the role of happiness in health optimization.  [00:03:07] Personal habits, nostalgia, and how small pleasures contribute to overall well-being.  [00:06:45] Rising prescription drug costs and why systemic reform remains difficult.  [00:07:57] Real-world example of high medication costs and patient financial burden.  [00:09:38] Lack of confidence in meaningful healthcare reform due to entrenched interests.  [00:12:25] Growing trend of patients turning to experimental treatments and self-directed care.  [00:13:45] Definition of peptides and explanation of their role in medicine.  [00:15:01] Distinction between clinically approved peptides and influencer-driven “biohacking” peptides.  [00:16:19] Origins of popular peptides and the gap between theory and proven outcomes.  [00:19:37] Cost-benefit concerns and limited real-world effectiveness of many peptide therapies.  [00:20:49] Overview of the “Wolverine blend” and lack of strong human data supporting it.  [00:23:29] Broader trend of distrust in traditional medicine driving risky alternatives.  [00:27:01] Appropriate use cases for peptides as a last-resort or experimental option.  [00:27:38] Risks of black-market peptides including contamination and inaccurate dosing.  [00:29:30] Independent testing reveals inconsistencies and dangers in unregulated peptide sources.  [00:35:36] Case study of AI misinformation influencing critical medical decisions.  [00:37:15] Risks of relying on a single information source for health decisions.  [00:39:59] Example of poor decision-making driven by overconfidence and misinformation.  [00:41:01] Introduction to key lessons from major studies on human happiness.  [00:41:01] Reducing time spent on unfulfilling activities and reassessing priorities.  [00:44:48] Importance of pursuing hobbies for enjoyment rather than mastery.  [00:47:17] Trying new activities purely for fun and personal fulfillment.  [00:48:15] Re-evaluating goals to align with purpose rather than outcomes.  [00:49:35] Avoiding comparison and reducing influence from unrealistic online personas.  [00:50:40] Benefits of social interaction beyond existing friend groups and engaging with new perspectives.    Links:  * BetterLife: https://www.joinbetterlife.com/about-us [https://www.joinbetterlife.com/about-us]  * Dr. David Janarious on LinkedIn: https://www.linkedin.com/in/david-janarious-8b6073280 [https://www.linkedin.com/in/david-janarious-8b6073280]  * Production and editing by The Podcast Consultant:  [https://thepodcastconsultant.com/]https://thepodcastconsultant.com  [https://thepodcastconsultant.com/]